NEO - NeoGenomics Inc (Healthcare: Diagnostics & Research) Projected Earnings Date: 2025-02-04    (Delayed quote data   2025-01-03)
Last
 16.98		 Change
 ⇑ +0.49   (+2.97%)		 Volume
  449,566
Open
 16.58		 High
 17.10		 Low
 16.58
8EMA (Daily)
 16.83		 40EMA (Daily)
 16.60		 50EMA (Daily)
 16.44		 STO (Daily)
 23.196		 MACD Hist (Daily)
 -0.222
8EMA (Weekly)
 16.640		 40EMA (Weekly)
 15.61		 50EMA (Weekly)
 15.54		 STO (Weekly)
 72.011		 MACD Hist (Weekly)
 0.385
Company Profile
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com